SCHEMBL4704339

SCHEMBL4704339

FC(F)(F)c1cc(-n2nnc(-c3ccccn3)n2)ccc1Br

nearest known ligand 0.64

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 17/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13683944 0.87 GRM5 (0.69) GRM5
SCHEMBL4703812 0.84 GRM5 (0.63) GRM5
SCHEMBL4703247 0.81 GRM5 (0.63) GRM5
SCHEMBL4699576 0.81 GRM5 (0.58) GRM5
SCHEMBL4698737 0.79 GRM5 (0.68) GRM5
SCHEMBL4702667 0.79 GRM5 (0.63) GRM5
SCHEMBL4698623 0.79 GRM5 (0.61) GRM5
SCHEMBL4702133 0.79 GRM5 (0.67) GRM5
SCHEMBL4699537 0.79 GRM5 (0.65) GRM5
SCHEMBL13683910 0.78 GRM5 (1.00) GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1434773-B1 HETEROARYL SUBSTITUTED TETRAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 MERCK & CO INC (US) 2008-05-21 EP claimed
WO-2004030637-A2 TREATMENT OF OBESITY AND OTHER DISORDERS ASSOCIATED WITH EXCESSIVE FOOD INTAKE MERCK & CO., INC. (US) 2004-04-15 WO claimed
US-7253190-B2 Heteroaryl substituted tetrazole modulators of metabotrophic glutamate receptor-5 MERCK & CO., INC. (US) 2007-08-07 US disclosed